Synlogic appoints michael heffernan to its board of directors

Cambridge, mass., dec. 9, 2020 /prnewswire/ -- synlogic, inc. (nasdaq: sybx), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced the appointment of michael heffernan to its board of directors. "we are delighted to welcome mike...
SYBX Ratings Summary
SYBX Quant Ranking